The Canadian Cardiovascular Society worked with other groups to put out resource for healthcare professionals while the ACE inhibitor is in short supply.
INESSS is updating its national medical protocol and group prescription template for medication adjustment and monitoring in adults with primary hypertension, and releasing a new guide for clinicians.
Canadian researchers examine whether thromboprophylaxis with low-dose ASA alone is inferior to five days of rivaroxaban followed by ASA after total hip/knee arthroplasty.